M Campbell
About
In The Last Decade
M Campbell
29 papers receiving 910 citations
Peers
Comparison fields: 5 of 76
- Psychiatry and Mental health 700
- Cognitive Neuroscience 535
- Clinical Psychology 376
- Genetics 153
- Pediatrics, Perinatology and Child Health 124
Countries citing papers authored by M Campbell
This map shows the geographic impact of M Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Campbell more than expected).
Fields of papers citing papers by M Campbell
This network shows the impact of papers produced by M Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Campbell. The network helps show where M Campbell may publish in the future.
Co-authorship network of co-authors of M Campbell
This figure shows the co-authorship network connecting the top 25 collaborators of M Campbell. A scholar is included among the top collaborators of M Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Campbell. M Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 27 | |
| 3 | Resolved: autistic children should have a trial of naltrexone. | 10 |
| 4 | 79 | |
| 5 | Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children. | 37 |
| 6 | Haloperidol in schizophrenic children: early findings from a study in progress. | 80 |
| 7 | Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot study. | 60 |
| 8 | Pimozide in autistic children. | 34 |
| 9 | Factors related to haloperidol response and dyskinesias in autistic children. | 30 |
| 10 | Naltrexone in autistic children: a double-blind and placebo-controlled study. | 56 |
| 11 | Diagnostic criteria and behavior patterns in infantile autism. | 6 |
| 12 | Naltrexone in infantile autism. | 54 |
| 13 | Documentation of demographic data and family history of psychiatric illness. | 3 |
| 14 | 4 | |
| 15 | 212 | |
| 16 | 99 | |
| 17 | A study of haloperidol in young autistic children: a within-subjects design using objective rating scales. | 12 |
| 18 | Demographic and perinatal profile of 105 autistic children: a preliminary report [proceedings]. | 14 |
| 19 | Pharmacotherapy in early infantile autism. | 27 |
| 20 | 22 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.